Intractable & Rare Diseases Research
Online ISSN : 2186-361X
Print ISSN : 2186-3644
ISSN-L : 2186-3644
Reviews
The progress of early growth response factor 1 and leukemia
Jing TianZiwei LiYang HanTao JiangXiaoming SongGuosheng Jiang
著者情報
ジャーナル フリー

2016 年 5 巻 2 号 p. 76-82

詳細
抄録

Early growth response gene-1 (EGR1) widely exists in the cell nucleus of such as, zebrafish, mice, chimpanzees and humans, and it also can be observed in the cytoplasm of some tumors. EGR1 was named just after its brief and rapid expression of different stimuli. Accumulating studies have extensively demonstrated that the widespread dysregulation of EGR1 is involved in hematological malignancies such as human acute myeloid leukemia (AML), chronic myelogenous leukemia, chronic lymphocytic leukemia, multiple myeloma, and B cell lymphoma. With the deep research on EGR1, its expression, function and regulatory mechanism has been gradually elucidated, and provides more possibilities for treatment strategies of patients with leukemia. Herein, we summarize the roles of EGR1 in its biological function and relationship with leukemia.

著者関連情報
© 2016 International Research and Cooperation Association for Bio & Socio-Sciences Advancement
前の記事 次の記事
feedback
Top